Invention Grant
- Patent Title: Use of bulleyaconitine A
-
Application No.: US17293941Application Date: 2019-06-13
-
Publication No.: US12042486B2Publication Date: 2024-07-23
- Inventor: Xianguo Liu , Biao Li , Qiongfen Wu
- Applicant: YUNNAN HAOPY PHARMACEUTICALS LTD
- Applicant Address: CN Yunnan
- Assignee: YUNNAN HAOPY PHARMACEUTICALS LTD
- Current Assignee: YUNNAN HAOPY PHARMACEUTICALS LTD
- Current Assignee Address: CN Yunnan
- Agency: BakerHostetler
- Priority: CN 1811376531.5 2018.11.19
- International Application: PCT/CN2019/091049 2019.06.13
- International Announcement: WO2020/103435A 2020.05.28
- Date entered country: 2021-05-14
- Main IPC: A01N37/00
- IPC: A01N37/00 ; A01N25/00 ; A01N37/12 ; A01N37/44 ; A61K9/00 ; A61K9/08 ; A61K9/20 ; A61K9/28 ; A61K9/48 ; A61K9/70 ; A61K31/215 ; A61K31/24 ; A61K31/439 ; A61K47/02 ; A61K47/44 ; A61P17/04
Abstract:
The present disclosure belongs to the field of pharmaceuticals. Disclosed is a use of bulleyaconitine A in treating pruritus or a secondary lesion thereof, especially pruritus induced by histamine and/or chloroquine.
Public/Granted literature
- US20220000846A1 USE OF BULLEYACONITINE A Public/Granted day:2022-01-06
Information query
